# Leibniz-Institut für Arterioskleroseforschung an der Universität Münster eV

> research institute

**Wikidata**: [Q101374701](https://www.wikidata.org/wiki/Q101374701)  
**Source**: https://4ort.xyz/entity/leibniz-institut-fur-arterioskleroseforschung-an-der-universitat-munster-ev

## Summary
Leibniz-Institut für Arterioskleroseforschung an der Universität Münster eV is a research institute focused on atherosclerosis research, located in Münster, Germany. It is part of the University of Münster and operates as a nonprofit organization (eV).

## Key Facts
- **Type**: Research institute specializing in atherosclerosis research
- **Country**: Germany
- **Headquarters**: Münster
- **Affiliation**: Part of the University of Münster
- **Legal form**: Nonprofit organization (eV)
- **Ringgold ID**: 28387
- **Fragdenstaat public body ID**: 720

## FAQs
### Q: What does Leibniz-Institut für Arterioskleroseforschung an der Universität Münster eV research?
A: The institute focuses on atherosclerosis, a leading cause of cardiovascular diseases, conducting research to advance understanding and treatment of the condition.

### Q: Is this institute affiliated with a university?
A: Yes, it is part of the University of Münster, collaborating with academic institutions for research and education.

### Q: Where is the institute located?
A: The institute is headquartered in Münster, Germany.

### Q: What is the legal status of the institute?
A: It operates as a nonprofit organization (eV), meaning it is a registered association under German law.

### Q: How can I identify this institute in public records?
A: It is registered with Fragdenstaat under ID 720 and has a Ringgold ID of 28387 for institutional identification.

## Why It Matters
Leibniz-Institut für Arterioskleroseforschung an der Universität Münster eV plays a crucial role in advancing atherosclerosis research, which is a major global health concern. By studying the underlying mechanisms of this disease, the institute contributes to the development of better diagnostic tools, treatments, and preventive strategies. Its work supports cardiovascular health research, benefiting both medical professionals and patients. As part of the University of Münster, it also fosters academic collaboration, integrating research with education and training. The institute’s contributions help reduce the burden of cardiovascular diseases, a leading cause of mortality worldwide.

## Notable For
- Specializes in atherosclerosis research, a key focus in cardiovascular medicine
- Affiliated with the University of Münster, enhancing academic and research collaboration
- Operates as a nonprofit organization (eV), ensuring independent and mission-driven research
- Registered with Fragdenstaat and Ringgold, facilitating institutional recognition and transparency
- Located in Münster, Germany, contributing to regional and national research networks

## Body
### Overview
Leibniz-Institut für Arterioskleroseforschung an der Universität Münster eV is a dedicated research institute focused on atherosclerosis, a leading cause of cardiovascular diseases. It conducts cutting-edge research to improve understanding and treatment of the condition.

### Location and Affiliation
The institute is headquartered in Münster, Germany, and is part of the University of Münster. This affiliation allows for collaboration with academic institutions, enhancing research and education.

### Legal and Institutional Identification
The institute operates as a nonprofit organization (eV), meaning it is a registered association under German law. It is identified by the Ringgold ID 28387 and the Fragdenstaat public body ID 720, ensuring transparency and institutional recognition.

### Research Focus
The primary focus of the institute is atherosclerosis, a condition characterized by the hardening and narrowing of arteries. Research conducted here aims to develop better diagnostic tools, treatments, and preventive strategies for this disease.

### Impact and Significance
The institute’s work is crucial for advancing cardiovascular health research. By studying atherosclerosis, it contributes to reducing the global burden of cardiovascular diseases, which are a leading cause of mortality. Its research supports medical advancements and patient care.

## References

1. Aligned ISNI and Ringgold identifiers for institutions